05 September 2008
Notification of Interim Results
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that its interim results for the half year ended 30 June 2008 will be announced on Friday 19 September 2008.
A meeting for analysts will be held at 10am on 19 September 2008 at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.co.uk
www.futuramedical.co.uk
Nominated Adviser:
Canaccord Adams Limited
Ryan Gaffney / Adria Da Breo
Tel: +44 (0) 20 7050 6500
For any media enquiries please contact:
Buchanan Communications Limited
Mark Court
markc@buchanan.uk.com
Rebecca Skye Dietrich
rebeccad@buchanan.uk.com
+44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of
the London Stock Exchange.